Cargando…
Effect of growth hormone cotreatment in sub-fertile women ≥ 40 years: a meta-analysis
Treatment of sub-fertile women aged ≥ 40 years old (advanced maternal age (AMA)) is challenging. Co-treatment with growth hormone (GH) is suggested to improve reproductive outcomes in poor responders. However, few studies, and with conflicting results, focused on women of AMA. A systematic review an...
Autores principales: | Elkalyoubi, Mohamed, Schindler, Larissa, Zaheer, Hena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083671/ https://www.ncbi.nlm.nih.gov/pubmed/36807147 http://dx.doi.org/10.1530/RAF-22-0107 |
Ejemplares similares
-
Growth Hormone Cotreatment for Low-Prognosis Patients According to the POSEIDON Criteria
por: Liu, Xueying, et al.
Publicado: (2021) -
Gonadotropin-Releasing Hormone Analog Cotreatment for the Preservation of Ovarian Function during Gonadotoxic Chemotherapy for Breast Cancer: A Meta-Analysis
por: Wang, Chuan, et al.
Publicado: (2013) -
Growth hormone supplementation may improve the pregnancy rate and endometrial receptivity among women aged more than 40 years undergoing in vitro fertilization
por: Lan, Kuo-Chung, et al.
Publicado: (2019) -
Effectiveness of Cotreatment with Kuntai Capsule and Climen for Premature Ovarian Failure: A Meta-Analysis
por: Ma, Qianwen, et al.
Publicado: (2020) -
Cotreatment of Congenital Measles with Vitamin A and Intravenous Immunoglobulin
por: Ozsurekci, Yasemin, et al.
Publicado: (2014)